Patient Compliance

Patients with dry eye disease experienced relief as early as 3 days after using Miebo, according to research presented at TFOS 2024.

Patients with mild/moderate obstructive sleep apnea treated with a mandibular advancement device plus expiratory positive airway pressure reported improved sleep quality at 6 months, according to a study poster.

Vevye, a nonpreserved cyclosporine 0.1% ophthalmic solution, demonstrated sustained safety and efficacy among patients with dry eye disease, according to 52-week ESSENCE-2 open-label extension study results published in Cornea.

Adherence to intravitreal anti-VEGF injections may be challenging for some patients with neovascular age-related macular degeneration, putting them at risk for poor vision outcomes, according to research published in Ophthalmology Science.

Dry eye disease is chronic, multifactorial and complex. As a result, management plans have to account for many variables, from underlying conditions to work environments.

Mind Medicine Inc. has announced an agreement with Catalent to use its Zydis orally disintegrating tablet technology for development of a new psychedelic-based anxiety treatment, according to a company press release.

CHARLOTTE, N.C. — In a Healio video exclusive, Eamonn Quigley, MD, reported increased compliance to an orally ingested vibrating capsule predicted positive outcomes among patients with chronic idiopathic constipation.

LAS VEGAS — To address patient need, affordability and physician-assisted treatment plans, a range of prevention therapies should be offered to those with migraines, according to a presenter at BRAINWeek 2022.

Red, irritated eyes and eyelids, fluctuating vision and ocular fatigue are common findings in patients with dry eye as well as those with glaucoma.

Glaucoma-related ocular surface disease is a significant and often underdiagnosed ocular comorbidity that can significantly affect quality of life.